Sitat av
Arne_J
Bare fordi cannabis kan ha positive virkninger på kreft betyr ikke at det skal legaliseres som rusmiddel... Tenkt på dèt, ts?
Det har jeg ikke kommentert verken i tittel eller mitt innlegg, ikke alle har kun et enkelt insentiv for å publisere medisinske artikler om cannabis (få det legalisert), selv om man lett mistenkeliggjøres for det.
Poster her en studie på ei jente med dødelig type Leukemia.(kreft på hvite blodceller) og hva cannabioder gjorde for behandlingen hennes. Det er vist i labtester hvor de gror kreftcellene og i dyr at blodtilførsel og cannabioder forhindrer videre vekst av kreftceller. I motsetning til andre typer kreftbehandling som cellegift og stråling håndterer kroppen cannabioder godt og produserer ikke giftig avfall. Se blodcelletellingen på bildet under, ved spikene tilførte de ekstra høye doser cannabisolje:
http://imgur.com/sN5aFoc (Link til bilde fordi forumet opererer med 2003-teknologi hva bildeopplasting angår.)
The results shown here cannot be attributed to the phenomenon of ‘spontaneous remission' because a dose response curve was achieved. Three factors, namely frequency of dosing, amount given (therapeutic dosing) and the potency of the cannabis strains, were critical in determining response and disease control. By viewing figure 6, it can be seen that introducing strains that were less potent, dosing at intervals >8 h and suboptimal therapeutic dosing consistently showed increases in the leukemic blast cell count. It could not be determined which cannabinoid profiles constituted a ‘potent' cannabis strain because the resin was not analyzed. Research is needed to determine the profile and ratios of cannabinoids within the strains that exhibit antileukemic properties.
http://www.karger.com/Article/FullText/356446#AC
The results shown here cannot be attributed to the phenomenon of ‘spontaneous remission' because a dose response curve was achieved. Three factors, namely frequency of dosing, amount given (therapeutic dosing) and the potency of the cannabis strains, were critical in determining response and disease control. By viewing figure 6, it can be seen that introducing strains that were less potent, dosing at intervals >8 h and suboptimal therapeutic dosing consistently showed increases in the leukemic blast cell count. It could not be determined which cannabinoid profiles constituted a ‘potent' cannabis strain because the resin was not analyzed. Research is needed to determine the profile and ratios of cannabinoids within the strains that exhibit antileukemic properties.
However, the numerous research studies and this particular clinical case are powerful enough to warrant implementing clinical trials to determine dose ranges, cannabinoid profiles and ratios, the methods of administration that produce the most efficacious therapeutic responses and the reproducibility of the results. It is tempting to speculate that, with integration of this care in a setting of full medical and laboratory support, a better outcome may indeed be achieved in the future.
http://www.karger.com/Article/FullText/356446#AC
Og ja; Slashdot: CANNABIS REDUSERER KREFT. Kanskje ikkje effektivt nok, eller leng nok til ein kur men du må gjerne eta hatten din.
Sist endret av flexx; 18. oktober 2015 kl. 23:40.
Grunn: Automatisk sammenslåing med etterfølgende innlegg.